94 results
New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial
29 Mar 2025
Luigi Biasco provides his take on a sub-analysis of the Early TAVR trial about the early and delayed aortic valve replacement implant patients presented by Philippe Genereux at ACC.25 in Chicago.
Author
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial
31 Mar 2025
Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.
Author
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.
Author
Two-year outcomes of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation: The Triluminate pivotal trial
02 Apr 2025
Alex Sticchi interviews Saibal Kar about the two-year results of the Triluminate pivotal trial, unveiled at ACC.25 in Chicago.
After revisiting the one-year findings and outlining the study design, Saibal Kar highlights key takeaways: at two years, TriClip therapy significantly reduced heart failure hospitalisations compared to medical...
Author
Author
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial
29 Mar 2025
Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.
Author
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
Clinical and echocardiographic outcomes among the first 500 patients treated with a dedicated transcatheter aortic valve for pure aortic regurgitation in the Align-AR clinical trial
31 Mar 2025
Jonathan Curio interviews Raj Makkar about the results of the Align-AR trial which he presented during the ACC.25 in Chicago.
Author
Author
Routine cerebral embolic protection in transcatheter aortic valve implantation: the British Heart Foundation (BHF) PROTECT-TAVI trial
29 Mar 2025
Aaysha Cader and Ali Nazmi Calik provide their take on the BHF PROTECT-TAVI trial, presented by Rajesh Kharbanda at ACC.25 in Chicago.
Author
Author
The main results of the phase 3 Reverse-it trial
02 Apr 2025
Luis Ortega-Paz interviews Deepak L. Bhatt about the results of the Phase 3 Reverse-it trial which he presented during the ACC.25 in Chicago.
Author
Author
Dapagliflozin in patients undergoing transcatheter aortic valve implantation (DapaTAVI)
10 Apr 2025
Chiara De Biase interviews Sergio Raposeiras-Roubin about the results of the DapaTAVI trial which he presented during the ACC.25 in Chicago.
Author
Author
